VEOPOZ 200 mg/mL
Pozelimab · INJECTION, SOLUTION · Regeneron Pharmaceuticals, Inc.
No Recall History
Plain English
VEOPOZ is a injection, solution containing pozelimab at 200 mg/mL, taken intravenous. Manufactured by Regeneron Pharmaceuticals, Inc..
Key Facts
- Brand Name
- VEOPOZ
- Generic Name
- Pozelimab
- NDC Code (Product)
61755-014- Manufacturer
- Regeneron Pharmaceuticals, Inc.
- Strength
- 200 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761339
- Drug Class
- Complement Inhibitor [EPC]
- Marketing Start
- 08/18/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is VEOPOZ used for?
VEOPOZ contains Pozelimab. It is a injection, solution taken intravenous. Consult your doctor for specific uses.
Is VEOPOZ a controlled substance?
VEOPOZ is not classified as a controlled substance by the DEA.
What is the generic name for VEOPOZ?
The generic name for VEOPOZ is Pozelimab. There are no other listed brand versions of Pozelimab.
What is the NDC code for VEOPOZ 200 mg/mL?
The NDC (National Drug Code) for VEOPOZ 200 mg/mL is 61755-014, listed by Regeneron Pharmaceuticals, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)